bioAffinity Technologies, Inc. (BIAFW) is a publicly traded company in the Healthcare sector, operating within the Medical - Diagnostics & Research industry. The company is headquartered in San Antonio, DE, United States. The current CEO is Maria Zannes.
BIAFW has 57 full-time employees, listed on the NASDAQ Global Select, a market capitalization of $1.62M.
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.
